Global HR industry analyst Kathi Enderes shares new research on frontline workers and why CHROs need to adopt a “frontline-first” mindset.
Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Payroll Theory Training (April 13-14, 2026)" training has been added to ResearchAndMarkets.com's offering. Navigating the complexities of payroll ...
Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Payroll Training (April 13-16, 2026)" training has been added to ResearchAndMarkets.com's offering. Effective payroll management is vital for every ...
Noble Kronos flagship IEMs deliver cutting-edge 9-driver hybrid sound with titanium shells. Are these $4,500 earphones worth the hype and price? Now, before you roll your eyes at the $4,500 price tag ...
Kronos is a HOLD: TiO2 demand should rise, but KRO lacks operating leverage and control over key feedstocks to benefit from upside. KRO faces significant competition from Chinese producers, especially ...
Today (July 16) marks the 80th anniversary of the Trinity test, during which a team of U.S. scientists led by J. Robert Oppenheimer detonated the world’s first atomic bomb in the deserts of New Mexico ...
WICHITA, Kan. (KSNW) – Top distance runners from across the Midwest are making their way to Wichita this weekend for a brand-new track event aiming to raise the bar: the first-ever Kronos Race Night ...
(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common ...
Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...
Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...
Kronos Q324 sales volumes soared, offsetting flat TiO2 selling prices to deliver +22% YoY revenue growth along with improved profitability. The company faces high growth expectations as it integrates ...
On the heels Kronos Bio’s decision to can its last remaining clinical asset earlier this month, the company said it would roll out “significant expense reduction strategies” to buy itself more time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results